Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-21-006231
Filing Date
2021-08-30
Accepted
2021-08-30 17:21:25
Documents
90
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_082621p.htm   iXBRL 6-K 865809
2 EXHIBIT 99.2 exh_992.htm EX-99.2 174343
8 GRAPHIC pipe.jpg GRAPHIC 91403
9 GRAPHIC org.jpg GRAPHIC 70751
  Complete submission text file 0001171843-21-006231.txt   5463608

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ptgef-20210630.xsd EX-101.SCH 73294
4 XBRL CALCULATION FILE ptgef-20210630_cal.xml EX-101.CAL 53669
5 XBRL DEFINITION FILE ptgef-20210630_def.xml EX-101.DEF 151696
6 XBRL LABEL FILE ptgef-20210630_lab.xml EX-101.LAB 284649
7 XBRL PRESENTATION FILE ptgef-20210630_pre.xml EX-101.PRE 261630
10 EXTRACTED XBRL INSTANCE DOCUMENT f6k_082621p_htm.xml XML 1017475
Mailing Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6
Business Address 6 ADELAIDE ST. EAST SUITE 300 TORONTO A6 M5C 1H6 416-737-7600
PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40086 | Film No.: 211224559
SIC: 1311 Crude Petroleum & Natural Gas